Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Takeda presents new data for TAK-831

May 20, 2019

Design of an ATP-competitive chemical inhibitor of spastin

May 20, 2019

Esteve Pharmaceuticals presents dual CACNA2D1/NET ligands

May 17, 2019

Suven Life Sciences identifies muscarinic M1 receptor positive allosteric modulators

May 17, 2019

Chronos Therapeutics presents orexin OX1 and/or OX2 receptor antagonists

May 17, 2019

Researchers present updated data from SUNFISH study on risdiplam for SMA

May 17, 2019

Bayer describes new P2X purinoceptor 3 antagonists

May 16, 2019

New stroke therapy promotes motor recovery in mice

May 16, 2019

GABA-selective AAV therapy upregulates SCN1A to treat Dravet syndrome

May 16, 2019

InFlectis BioScience announces phase I results for IFB-088

May 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.